Browsing: Pharma

Phase 3 results “exceeded” BioMarin’s expectations, according to head of research and development Greg Freeberg,…

Biopharmaceutical sales were on the rise in the first quarter of this year, with eight…

The Ibsen-commissioned study identified widespread problems with the transition from pediatric to adult care, and…

Bristol-Myers Squibb is the latest major pharmaceutical company to bet big on artificial intelligence, announcing…

After about six years in the job, Amgen’s finance chief has written a letter announcing…

Tarsus Pharmaceuticals has spent the past three years marketing its efforts to overcome the little-known…

B-One Medicines has tapped former professional soccer goalkeeper Tim Howard as the face of its…

Two months after UCB revealed the success of Bimzerx in a head-to-head trial with AbbVie’s…

Roche has entered into a voluntary licensing agreement to provide the popular anti-influenza virus drug…

With questions already swirling about the real affordability impact of the government’s drug purchasing portal…